Maximize Your Impact at Discovery On Target 2026
Discovery On Target 2026, taking place September 28 to October 1 at the Sheraton Boston Hotel, brings together scientific and commercial leaders engaged in early drug discovery and target validation. Drawing researchers, biotech executives, therapeutic area leads, and translational medicine teams, the event is a crucial touchpoint for mid-to-late stage pipeline decisions and partnership exploration in categories such as oncology, neuroscience, and immunology.
The event serves as a strategic venue where R&D priorities are shaped, pharma scouts review academic data for licensing opportunities, and platform companies present target-specific advancements to align with emerging clinical approaches. Decision-makers in attendance come prepared to vet new solutions, initiate collaborations, and gather insights that inform large-scale investments.
Early engagement with attendees can help you identify which disease areas are gaining traction, which companies are entering new modalities, and who within organizations owns the budget authority for discovery-stage technologies. With Vendelux’s enriched list, outreach can be accurately timed and precisely segmented, helping your team approach the right stakeholders before their schedules fill up and priorities become locked in.
How Sales, Marketing and RevOps Teams Can Use This Attendee List
Discovery On Target attendees represent an intersection of science, strategy, and purchasing authority, making the enriched conference attendee list especially valuable for both commercial biotech teams and solution providers. Corporate development leaders, CROs, and technology vendors can use the data to segment prospects by company type—emerging biotech, top pharma, academic centers—and by role, such as head of biology, translational lead, or external innovation director.
Outreach can be customized to the strategic focus of each attendee’s scientific pathway, whether it’s kinase inhibitors, protein degradation, or gene therapies. Reach out to those managing bench-to-clinic programs before the show to secure meetings that center around resourcing needs, experimental design services, or co-development discussions.
By using the Vendelux attendee data early, your team can prioritize outreach to decision-makers evaluating new platforms or initiating preclinical investments. On-site, build higher-value relationships by knowing attendees’ affiliations and contribution areas beforehand. Post-event, follow-up becomes significantly more meaningful when aligned with what was presented, discussed, or announced during the sessions. This approach improves your ability to get more meetings, stay relevant, and convert registrations into extended partnerships.
Timing Is Everything
Discovery On Target 2026 takes place from September 28 to October 1, 2026. With more than 15 focused streams, it attracts senior stakeholders making time-sensitive R&D decisions. Given the scientific nature of the conference, participants often solidify their meeting schedules weeks in advance—especially those evaluating experimental partnerships or early-stage licenses.
Using Vendelux, sales and marketing teams can start identifying attendee matches months ahead and align their messaging to specific interest areas. Prior outreach boosts credibility and visibility, particularly when aligned with the ongoing discovery priorities of biotech and pharma audiences. Early engagement ensures that your solutions are positioned during key moments of planning and vendor assessment.
What’s Included in the Discovery On Target 2026 Attendee List?
Vendelux provides visibility into executives expected to attend Discovery On Target 2026 through a combination of organizer-disclosed information and predictive intelligence. Users can upload a list of target companies and receive matches within the full attendee list for higher prospect alignment.
The enriched attendee list includes first and last names, job titles, company names, company websites, geographic location information (city, state, country), LinkedIn profiles, verified email addresses, and business phone numbers when available.
Where Is Discovery On Target 2026?
The event will be held at the Sheraton Boston Hotel in Boston, Massachusetts, United States.
When Is Discovery On Target 2026?
Discovery On Target 2026 is scheduled for September 28 to October 1, 2026.
What Type of Event Is Discovery On Target 2026?
Discovery On Target is a scientific conference aimed at pharmaceutical discovery, early target validation, and translational medicine. It features scientific tracks, partnering forums, keynote sessions, and panel discussions. The structure is designed to encourage knowledge sharing and business interactions between researchers, biotech innovators, and pharma executives.
How Many People Attend Discovery On Target 2026?
The event is expected to host over 1,300 attendees from across North America, Europe, and Asia. The audience includes senior-level scientists, department heads, R&D strategists, business development executives, and therapeutic program leaders all focused on advancing early pipeline programs and cross-sector collaborations.
